Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kratos Awarded $48 Million Contract for Geolocation Global Support Services
-
STACK Infrastructure Advances Data Center Safety and Releases Breaker Guard Design into Public Domain
-
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
-
Acronis Appoints Gerald Beuchelt as Chief Information Security Officer
-
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
-
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
-
Advanced Ionics Raises $6.7M to Accelerate Technology Commercialization and Deployment
-
Blimburn Seeds Announces USA Expansion
-
Collegium Provides 2025 Financial Guidance and Business Update
-
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2024 Financial Results
-
New TransUnion Research Reveals Seven in 10 Marketing Leaders Struggle to Connect with Audiences Due to Complex Network of Martech Solutions and Identity Challenges
-
Bonaccord Capital Partners Announces Fund II Final Close at $1.6 Billion
-
Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Horizon Aircraft Announces Exercise of Warrants, Providing an Additional $2.7 Million in Gross Proceeds
-
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
-
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Notice of annual general meeting of Gabriel Holding A/S
-
Copenhagen Infrastructure Partners charges to the top of the UK battery stack
-
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology
-
BitMEX Launches Multi Asset Margining: Simplifying Trading for Derivatives Markets
-
Form 8.3 - Warpaint London Plc
-
Form 8.3 - Renewi Plc
-
Form 8.3 - Learning Technologies Group Plc
-
Alliance Witan PLC - Net Asset Value
-
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
-
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Amplify ETFs to Liquidate the Amplify U.S. Alternative Harvest ETF (MJUS)
-
Nayax, the Leader in Seamless Payment and Commerce Solutions, Set to Unveil 'Retail Your Way' at NRF 2025
-
Angitia Biopharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
-
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
-
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
-
Gaxos to Participate in The Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico
-
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
-
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
-
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
GURU Organic Energy Announces Appointment of New Executive Vice President, Sales
-
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
-
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
-
Atsena Therapeutics Initiates Part B of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis
-
RAID: Shadow Legends Steps Into the Rabbit Hole with ‘RAID: Alice’s Adventure’ Special Event
-
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
-
Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
-
Lithium Argentina Provides 2024 Production Results, 2025 Guidance and Update on Special Meeting of Shareholders
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
uniQure Announces Pricing of its Public Offering
-
Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
-
RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top 10 Best-Selling Master Planned Communities of 2024
-
CommunityAmerica Credit Union Accelerates St. Louis Expansion, Merging with Electro Savings Credit Union
